ACADIA Pharmaceuticals Inc. (ACAD)
USD 14.66
(0.58%)
USD 14.66
(0.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 726.43 Million | 517.23 Million | 484.14 Million | 441.75 Million | 339.07 Million | 223.8 Million |
| Cost of Revenue | 45.73 Million | 10.16 Million | 19.14 Million | 20.55 Million | 19.59 Million | 18.33 Million |
| Gross Profit | 680.7 Million | 507.06 Million | 465 Million | 421.2 Million | 319.47 Million | 205.47 Million |
| Operating Expenses | 754.08 Million | 730.66 Million | 635.44 Million | 707.79 Million | 566.02 Million | 452.92 Million |
| Selling, General and Administrative Expenses | 402.46 Million | 369.09 Million | 396.02 Million | 388.66 Million | 325.63 Million | 265.75 Million |
| Research and Development Expenses | 351.61 Million | 361.57 Million | 239.41 Million | 319.13 Million | 240.38 Million | 187.16 Million |
| Other Expenses | - | 3.54 Million | 2.32 Million | -997 Thousand | 997 Thousand | -1.84 Million |
| Cost and Expenses | 799.81 Million | 740.83 Million | 654.58 Million | 728.34 Million | 585.62 Million | 471.25 Million |
| Operating Income | -73.37 Million | -223.59 Million | -170.43 Million | -286.58 Million | -246.54 Million | -247.44 Million |
| Interest Expense | - | 6.61 Million | - | - | - | - |
| Income Tax Expense | 10.25 Million | 2.53 Million | 351 Thousand | 611 Thousand | 876 Thousand | 1.25 Million |
| Earnings before Tax | -51.03 Million | -213.44 Million | -167.51 Million | -280.97 Million | -234.38 Million | -243.93 Million |
| Net Income | -61.28 Million | -215.97 Million | -167.87 Million | -281.58 Million | -235.25 Million | -245.19 Million |
| Earnings Per Share Basic | -0.37 | -1.34 | -1.05 | -1.79 | -1.60 | -1.94 |
| Earnings Per Share Diluted | -0.37 | -1.34 | -1.05 | -1.79 | -1.60 | -1.94 |
| Weighted Average Shares Outstanding | 163.81 Million | 161.68 Million | 160.49 Million | 157.33 Million | 147.19 Million | 126.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 163.81 Million | 161.68 Million | 160.49 Million | 157.33 Million | 147.19 Million | 126.58 Million |
| Gross Margin | 0.94 | 0.98 | 0.96 | 0.95 | 0.94 | 0.92 |
| EBIT Margin | -0.09 | -0.43 | -0.35 | -0.65 | -0.73 | -1.11 |
| Profit Margin | -0.08 | -0.42 | -0.35 | -0.64 | -0.69 | -1.10 |
| EBITDA | -67.82 Million | -221.57 Million | -167.09 Million | -286.58 Million | -243.77 Million | -244.43 Million |
| Earnings Before Tax Margin | -0.10 | -0.43 | -0.35 | -0.65 | -0.73 | -1.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 241.96 Million | 205.83 Million | 726.43 Million | 231.04 Million | 211.69 Million | 165.23 Million |
| Cost of Revenue | 18.23 Million | 22.95 Million | 45.73 Million | 17.89 Million | 14.62 Million | 7.45 Million |
| Gross Profit | 223.73 Million | 182.88 Million | 680.7 Million | 213.15 Million | 197.07 Million | 157.77 Million |
| Operating Expenses | 193.29 Million | 167.67 Million | 754.08 Million | 178.2 Million | 254.85 Million | 154.73 Million |
| Selling, General and Administrative Expenses | 117.06 Million | 107.99 Million | - | 111.46 Million | 97.89 Million | 95.96 Million |
| Research and Development Expenses | 76.23 Million | 59.67 Million | - | 66.74 Million | 156.96 Million | 58.77 Million |
| Other Expenses | 386 Thousand | 286 Thousand | 5.1 Million | - | 1.5 Million | -1.24 Million |
| Cost and Expenses | 211.52 Million | 190.62 Million | 799.81 Million | 196.09 Million | 269.47 Million | 162.19 Million |
| Operating Income | 30.43 Million | 15.21 Million | -73.37 Million | 34.94 Million | -57.77 Million | 3.03 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.79 Million | 4.44 Million | 10.25 Million | -6.09 Million | 13.03 Million | 5.22 Million |
| Earnings before Tax | 37.18 Million | 21 Million | -51.03 Million | 39.7 Million | -52.14 Million | 6.34 Million |
| Net Income | 33.38 Million | 16.55 Million | -61.28 Million | 45.79 Million | -65.17 Million | 1.11 Million |
| Earnings Per Share Basic | 0.20 | 0.10 | - | 0.28 | -0.40 | 0.01 |
| Earnings Per Share Diluted | 0.20 | 0.10 | - | 0.28 | -0.40 | 0.01 |
| Weighted Average Shares Outstanding | 165.55 Million | 164.79 Million | 163.81 Million | 164.81 Million | 164.23 Million | 163.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 166.17 Million | 166.62 Million | 163.81 Million | 166.51 Million | 164.23 Million | 165.04 Million |
| Gross Margin | 0.92 | 0.89 | 0.94 | 0.92 | 0.93 | 0.95 |
| EBIT Margin | 0.14 | 0.10 | - | 0.16 | -0.27 | 0.02 |
| Profit Margin | 0.14 | 0.08 | -0.08 | 0.20 | -0.31 | 0.01 |
| EBITDA | 33 Million | 20.73 Million | - | 36.58 Million | -57.77 Million | 3.03 Million |
| Earnings Before Tax Margin | 0.13 | 0.07 | -0.10 | 0.15 | -0.27 | 0.02 |
NETLINK
CRI
ACQ
002938
TRN
PDRX